Investors

Insider Transactions

Date Name Title Type Shares Traded Price Range Sorted Descending
Oct 27, 2014 schleifer leonard s Officer Automatic Sell 138,426 402.69
Nov 17, 2014 terifay robert j Officer Automatic Sell 26,388 401.75
Oct 28, 2014 schleifer leonard s Officer Automatic Sell 69,112 400.52 - 410.00
Nov 18, 2014 terifay robert j Officer Automatic Sell 22,362 400.45 - 408.62
Nov 12, 2014 schleifer leonard s Officer Automatic Sell 42,324 400.22 - 401.12
Oct 31, 2014 schleifer leonard s Officer Automatic Sell 3,453 400.11
Nov 11, 2014 schleifer leonard s Officer Automatic Sell 3,493 400.00
Nov 13, 2014 van plew daniel p Officer Sell 8,575 399.21 - 399.95
Oct 24, 2014 brown michael s Director Automatic Sell 5,000 399.00
Nov 12, 2014 van plew daniel p Officer Disposition (Non Open Market) 10,125 398.93
Nov 12, 2014 goldstein joseph l Director Sell 5,000 398.31
Oct 24, 2014 goldberg murray a Officer Automatic Sell 26,788 395.96 - 404.18
Oct 23, 2014 goldberg murray a Officer Automatic Sell 33,212 391.93
Aug 18, 2014 mccorkle douglas s Officer Automatic Sell 5,875 353.00
Aug 27, 2014 tessier-lavigne marc Director Sell 3,000 352.20
Aug 26, 2014 tessier-lavigne marc Director Disposition (Non Open Market) 200 351.62
Aug 26, 2014 vagelos p roy Officer Disposition (Non Open Market) 161,597 351.62
Aug 27, 2014 yancopoulos george Officer Disposition (Non Open Market) 5,426 351.33
Aug 18, 2014 aberman michael s Officer Automatic Sell 5,139 351.06
Sep 8, 2014 vagelos p roy Officer Automatic Sell 2 351.00
Showing 1-20 of 863 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44  See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)